a biopharmaceutical company developing targeted payload immunotherapeutic for the treatment of advanced cancers
Industry Biotechnology
A.I.dvisor indicates that over the last year, ATNM has been loosely correlated with GBIO. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if ATNM jumps, then GBIO could also see price increases.
Ticker / NAME | Correlation To ATNM | 1D Price Change % | ||
---|---|---|---|---|
ATNM | 100% | -3.51% | ||
GBIO - ATNM | 46% Loosely correlated | -8.20% | ||
XNCR - ATNM | 38% Loosely correlated | -0.47% | ||
AURA - ATNM | 38% Loosely correlated | -3.48% | ||
PGEN - ATNM | 37% Loosely correlated | -3.58% | ||
NTLA - ATNM | 36% Loosely correlated | -6.15% | ||
More |
Ticker / NAME | Correlation To ATNM | 1D Price Change % |
---|---|---|
ATNM | 100% | -3.51% |
cancer theme (82 stocks) | 45% Loosely correlated | -2.35% |
drugs theme (254 stocks) | 43% Loosely correlated | -1.67% |
biopharmaceuticals theme (50 stocks) | 35% Loosely correlated | -2.60% |
biotechnology theme (238 stocks) | 26% Poorly correlated | -1.76% |
immunotherapy theme (12 stocks) | 14% Poorly correlated | -6.14% |